Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Added more today at $10.00. Love the potential!
Current valuation seems to ignore likely developments in the near future.
Tiny, poorly designed trials...Squandered time, money and lives!
CEO malpractice. Continues sucking-up to FDA for attempted Hail Mary approval.
Something so corrupt impeding something seemingly so wonderful.
Tragically, CEO expertise/concerns seem confined to lust for self-enrichment.
Those forms, design and preparation remain impeccably astute.
End the circus side-show.
Install competent CEO.
Or sell this mess.
Or... Keep bumming around the world's landscape like a failed snake-oil purveyor.
Justifications, emotion and wrong assumptions destroy investor wealth!
The markets are rigged against small retail investors.
Liken it to Las Vegas. That's just the way it is.
Shorting is but one example of retail investor abuse.
Illegal naked shorting also remains profitable.
At least be aware of the game before playing; or perhaps being played.
Have you never read the SEC hand-slap settlements, always without admitting guilt?
And that's in the extremely rare circumstance where any action is even taken.
Scorn for others here trying to help you is no substitute for appreciation.
Imagine shorting, w/board seat and inside information!
Or, supporting the devil you know...
Interesting times.
Use of Proceeds changes/uncertainty remains troubling!
The Closing Announcement PR offers the best spin on the use of proceeds..
Hopefully they gain focus with purpose and don't stumble into another mess.
Enjoy, but remember Roth is a placement agent!
I hold little regard for most stock analysts, weather forecasters and fortune-tellers.
Well I was a buyer...Below $5.00 a bargain!
They have got to do something with the cash.
They are no longer 'investing' in CD'S.
Under $5.10 looked to be a very good opportunity.
Added shares on off-chance they finally license/sell something!
Looks like the share price is ready to move up another level soon.
Hope all the money they have been raising was well spent.
$4.23
About $5.50 seems right...~$5.30 reflects unknown, pending news/purpose!
Noise will abate soon.
Reason will soon prevail.
Dilution can be good or bad.
Ceramic vision aims for an even brighter future!
Competitors facing tall climb just playing catch-up; seem to lack leadership.
Terms of industrial partnership certainly deserve a closer look.
Very interesting.
Thanks for sharing.
Favorable market sector/environment continues to settle into place!
Bottom near, but missing the shake to set things right for building new base.
China restrictions and new governmental money flow to control pace.
Opens up a lot of opportunities for the future!
A very timely and prudent move for a growing business.
Control issues, but seemingly friendly to existing shareholders.
Especially interesting given Virtra's current record cash position strength.
And now at a hundred employees... Strategic military efforts may finally blossom.
Shares and cash coupled with Bob's insidious frugality spells transformation.
Merger? Acquisition?? New applications, products or entirely new product line(s)???
Or, perhaps 165,956,484 shares traded on 7,775,030 outstanding shares remains coincidental.
http://ih.advfn.com/stock-market/NASDAQ/virtra-VTSI/stock-news/84709241/virtra-announces-pricing-of-18-0-million-register
Loaded up today...I'll chance the bottom is near!
Freefall/overreaction had clearly taken on a life of its own.
Redemption!
Massive job posting/hiring remains the conformation!
My anxiety remains as to growth rate vs quality standards using outside concerns thereby allowing unlimited project development. Would like to hear more regarding some core company presence and on-site guidance related to standards; both quality control and performance.
I remain very content observing what appears to be an excellent product mix/demand proposition, modulating extreme growth development both now and beyond the horizon.
Hoghead7, thanks for sharing your excellent research!
News ambiguity intentional... Smells of smoke and mirrors!
Pattern has developed. No way your reasonable request will be honored.
Don't you realize the efforts and pains being taken performing said tap-dance?
Question being who profits... Certainly not the average common shareholder!!!
Complaints by shareholders to SEC may become necessary.
Overlooking their occasional oversights has emboldened this mess.
All in my opinion, believing those responsible to be literate.
Incomplete/omission of material information needs regulatory scrutiny!
Unfortunately, the Board of Directors have failed taking necessary immediate corrective actions, thereby allowing these actions to continue.
This deficient pattern regarding releasing material information must be addressed and corrected, seemingly now by securities regulators.
Given ongoing lapses, perhaps a closer look into other Corporate actions/inactions will also become prudent or even necessary.
As a shareholder, I fear these problems/issues beyond that of any drug acceptance, approval delays or even failures.
They appeared proactive, but COVID obviously consequential!
Would have liked to hear more about problems, impacts, workarounds and solutions.
Future construction/completion impacts and issues in USA would seem brightest near-term.
Management needs to tighten-up...But too GREEN to fail!
They have expanded their footprint enough to earn some passes, but results matter.
Also seems they are becoming way too comfortable with their own performance.
Fortunately, they have multiple paths available for profits and success.
Welcome to the buy zone... I got mine!
Thanks, $2.28
NP not precise?..His carnival shill-show guts all credibility!
Endless, incomplete tap-dance with every news results/release even boggles believers.
Constant half-assed snake-oil presentations indeed likens the product to snake-oil.
Shortcuts continue to be the long way around receiving approvals.
Meaningful, statistically relevant results should be #1 company endpoint.
Do it right the first time rather than constant patched-up cluster thingies.
Lack of approvals remains self-imposed, costing more and more lives every day.
Cytodyn seems ready to deal...First come, first served!
FDA or whoever provides the best path forward with Leronlimab-PRO approval.
----------------------------------------------------------
COVID-19 Phase 3 trial highlights include:
Survival benefit: 24% reduction in all case mortality
Shortened time to recovery: Average hospital stay reduced by 6 days
Discharge ALIVE: At day 28, 28% versus 11% / 166% better rate than placebo group.
------------------------------
WHATS NOT TO LIKE
------------------------------
Kind of like infomercial mentality... Current supply is limited, call now!!! (I think that's why Brazil was included)
I don't expect much more trial information details to be disclosed at Monday WC unless they release news/details over the wire prior.
Amazing strength, especially given the market correction!
Maybe it's the tee shirts...
Amazing RFP strength/recovery after a full market correction!
RFP appears to be even stronger than I had envisioned.
It can't hurt that construction numbers soared.
Good bargain again today, that may be about it!
Good volume going down and then on back up, so far.
Finished my buying and we'll see what happens.
Agree...Sell volume hurts SP now but helps later!
A great day for late arrivals like me to lower my cost average.
The more shares that come out today, the better it is.
Hoping some sort of new support base results.
GREEN is the color of money to be made here; be it next week, month or years.
Nice pull-back today... Had to load up!
ExxonMobil news from Monday!
https://www.msn.com/en-us/money/news/exxon-mobil-unveils-5-year-plan-to-meet-climate-change-goals-increase-shareholder-value/ar-BB1ecRtO?ocid=uxbndlbing
https://corporate.exxonmobil.com/News/Newsroom/News-releases/2019/1106_ExxonMobil-and-FuelCell-Energy-expand-agreement-for-carbon-capture-technology
Interesting read... Progress/clean-up confirmed on 10K!
They've sorted the dirt from the diamonds.
Cutting and polishing is set to begin.
Next Q's should grab interest.
The new greenhouse/products could also be interesting.
Improved U.S. relations will provide an additional profit boost.
Basic plan in place; needs better time milestones!
Could just be a flash from the PR for now...
We'll see if it can hold firm here.
Expanded machine shop efforts should reflect increased acceptance/sales!
Potentially indicating a marked increased in their favorable product profit mix.
Recoil Kits, Magazines and their M-4/M16 Non-Gun Training Rifles, etc.
Magic 8 Ball says... Efforts to be Rewarded.
Slow motion about to happen real time.
Perhaps up to about 100 employees.
Just a pull-back so far; needed a correction!
It's all about the tomorrow and beyond...
A lock until the REAL inflation, maybe near year's end.
Still needed to load up shares for the main journey that follows.
I added some shares today!
Still like the sector; like the company.
We'll see how it works out...
The 100% sensitivity and specificity remains key!
My money remains on ACCURACY.
Walgreens provides an excellent vehicle, especially important for providing product technology recognition and acceptance.
Current cost likely offset by test accuracy, convenience and self assurance. And no swab shoved up the nose... Plus availability; for travel, work and quarantine issues.
Reimbursement/payment coverage structures are always important and may happen, but will take time.
At-Home COVID-19 Saliva Test Available Through Walgreens!
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210224:nPncc9yhza&default-theme=true
The test costs $119 per kit.
CYDY on sale today for $3.97. Thank you!
Buying the dips.
I got mine.
As the approval process continues...
Tailwind in lumber markets!
BRENT JANG
VANCOUVER
Resolute Forest Products Inc. RFP-T +3.27%increase
chief financial officer Remi Lalonde recalls tense times for the company last spring, when the outlook seemed bleak for lumber demand.
“I think that when you look at 2020 and the pandemic-induced challenges that we had, there were some pretty scary moments, especially in March, April and May,” he said in an interview, days before he becomes Resolute’s new chief executive officer next week.
Mr. Lalonde remembers the forestry sector’s widespread fears last spring that U.S. housing starts would plummet in 2020, as they did during the 2008-09 recession.
Instead of crashing, however, lumber markets soared in the second half of 2020 amid a surprisingly brisk pace of U.S. housing starts.
Mr. Lalonde said while there is bound to be volatility in commodity prices in the cyclical forestry industry, he sees promising signs for the momentum in North America’s lumber sector to carry through 2021. “There’s going to be a tailwind in lumber markets for at least some time to come,” he said.
The lumber rally in the second half of 2020 more than offset weak demand for Resolute’s newsprint production and a lacklustre performance on the pulp and paper side.
“It turns out that with folks having to work remotely and adjust in the pandemic, it really pushed an increase in demand for housing starts,” Mr. Lalonde said. “It also drove a lot of demand into repair and remodelling activity.”
Benchmark two-by-fours made from Western spruce, pine and fir sold in mid-February for US$992 for 1,000 board feet, compared with US$402 at the same time last year, according to industry newsletter Madison’s Lumber Reporter.
“Home builders continue to see strong demand,” CIBC World Markets Inc. analyst Hamir Patel said in a research note last week.
Montreal-based Resolute’s gains on the Toronto Stock Exchange over the past 10 months reflect the company’s strength in wood products, with lumber prices hitting record highs this month.
Resolute’s share price on the TSX closed at $11.63 on Friday, down from its 52-week intraday high of $14.10 on Feb. 16, but still seven times higher than the record low of $1.63 in April, 2020.
“Folks are realizing that they’re going to be spending more time at home,” Mr. Lalonde said. “They’re building decks, they’re building fences – all to make the more time that they spend at home more comfortable.”
Mr. Lalonde, 44, will be taking over on March 1 as CEO from the retiring Yves Laflamme, a long-time Resolute executive who rose to the top job three years ago.
Mr. Lalonde joined Resolute in 2009 and has filled a wide range of roles over the years, including serving as general manager of its pulp and paper mill in Thunder Bay.
A franco-Ontarian, he graduated with an engineering degree from the University of Ottawa in 1999 and then earned his law degree from the same university in 2003.
Sylvain Girard, a former chief financial officer at SNC-Lavalin Group Inc. SNC-T -0.62%decrease
, will join Resolute to become its new CFO on March 2.
A major lingering concern for Mr. Lalonde and Mr. Girard will be the long-running trade dispute between Canada and the United States over softwood lumber.
In the latest round of the cross-border fight, the U.S. Department of Commerce began imposing duties on Canadian lumber in April, 2017. By the end of 2020, Resolute alone paid duties totalling US$243-million.
“The dispute has been very costly to the Canadian lumber sector,” Mr. Lalonde said. “Our perspective is that when we look at the past, international bodies have almost always sided with Canada throughout the dispute resolution process.”
The issue of Canadian lumber shipments into the U.S. is not a direct part of the North American free-trade agreement nor the U.S.-Mexico-Canada Agreement. But under NAFTA’s Chapter 19, Canada and the U.S. agreed to set up trade panels to settle disputes.
The USMCA, which took effect on July 1, 2020, retains that appeal process.
It remains to be seen whether the Biden administration will be motivated to resolve the softwood battle that dates back to the early 1980s. “But we think that with the new administration, there is an encouraging signal of change in tone,” Mr. Lalonde said. “We need them to embrace the rule of law and to be a fair, good-faith collaborator. Canada and the U.S. have a special relationship, and we need that to be restored.”
https://www.theglobeandmail.com/business/article-resolutes-incoming-ceo-envisages-strong-lumber-markets-through-2021/
Results would appear good...Only question being how good!
I did expect a better effort composing the news release.
Adding more shares at $3.95 certainly helped mellow the mess.
Loaded on the small pullback; ready to roll!
Expecting good housing, advertising leaps. Business demand surge!
Pent-up demand to explode as consumers run wild with cheap loans, free cash and vaccine.
Raising cash, buying. Staging time now for what will hit in the 2nd half of this year.
Todays jobs miss should have been expected after last months revisions.
Todays interest rate worry is just wall street being wall street.
All a prelude, setting up for huge problems later.
The printing press is king, until it isn't.
Green, renewables; huge opportunity awaits in many sectors.